GRAIL to Present at Morgan Stanley's 24th Annual Global Healthcare Conference
GRAIL (Nasdaq: GRAL) announced that its management will present at the Morgan Stanley 24th Annual Global Healthcare Conference in New York on Monday, September 14, 2026, at 11:30 a.m. ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
GRAIL (Nasdaq: GRAL) announced that its management will present at the Morgan Stanley 24th Annual Global Healthcare Conference in New York on Monday, September 14, 2026, at 11:30 a.m. ET. A live and replay webcast will be available via the investor relations section of GRAIL's website for at least 30 days.
Details
News Market Reaction – GRAL
On Sep 1, the first trading day after this news, GRAL closed 0.57% above the previous close. Argus tracked a peak move of +3.4% during that session. Our momentum scanner recorded 3 alerts in the available session data. Relative volume reached 1.8x the daily average during tracking.
Data tracked by StockTitan Argus for the Sep 1 session.
Key Figures
- Conference edition
- 24th annual
- Morgan Stanley Global Healthcare Conference
- Presentation date
- Sep. 14, 2026
- Morgan Stanley Global Healthcare Conference
- Presentation time
- 11:30 a.m. ET
- Sep. 14 presentation
- Replay availability
- at least 30 days
- Webcast archive
Historical Context
-
FDA advisory committee meeting scheduled to review Galleri PMA application
-
Q2 revenue growth accompanied by net loss and negative adjusted EBITDA
-
Management presentation at Canaccord Genuity annual growth conference
-
Company scheduled Q2 results release and management webcast
-
Priority Health collaboration expanded Galleri access to employer groups
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
A live and replay webcast may be accessed in the investor relations section of GRAIL's website at investors.grail.com. The webcast will be archived and available for reply for at least 30 days after the event.
About GRAIL
GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is focused on alleviating the global burden of cancer by using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. GRAIL's targeted methylation-based platform can support the continuum of care for screening and precision oncology, including multi-cancer early detection in symptomatic patients, risk stratification, minimal residual disease detection, biomarker subtyping, treatment and recurrence monitoring. GRAIL is headquartered in Menlo Park, CA with locations in Washington, D.C., North Carolina, and the United Kingdom.
For more information, visit grail.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/grail-to-present-at-morgan-stanleys-24th-annual-global-healthcare-conference-302865242.html
SOURCE GRAIL, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.